Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axsome Therapeutics, Inc. | 8,188 | reported | 21 Apr 2026 | tx 41+811,520−54,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Apr 2026 | GRANT_AWARD | Axsome Therapeutics, Inc. | 8,188 | 0.00 USD | deriv |
| 26 Feb 2026 | GRANT_AWARD | Axsome Therapeutics, Inc. | 18,570 | 0.00 USD | deriv |
| 22 Jan 2026 | EXERCISE | Axsome Therapeutics, Inc. | 12,000 | 3.50 USD | |
| 22 Jan 2026 | SALE | Axsome Therapeutics, Inc. | 12,000 | 187.92 USD | |
| 22 Jan 2026 | EXERCISE | Axsome Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 24 Feb 2025 | GRANT_AWARD | Axsome Therapeutics, Inc. | 9,423 | 0.00 USD | deriv |
| 21 Feb 2025 | GRANT_AWARD | Axsome Therapeutics, Inc. | 9,423 | 0.00 USD | deriv |
| 21 Feb 2025 | GRANT_AWARD | Axsome Therapeutics, Inc. | 9,516 | 0.00 USD | deriv |
| 13 Feb 2025 | EXERCISE | Axsome Therapeutics, Inc. | 12,000 | 3.50 USD | |
| 14 Feb 2025 | SALE | Axsome Therapeutics, Inc. | 3,000 | 131.07 USD | |
| 14 Feb 2025 | EXERCISE | Axsome Therapeutics, Inc. | 3,000 | 3.50 USD | |
| 13 Feb 2025 | SALE | Axsome Therapeutics, Inc. | 12,000 | 129.86 USD | |
| 13 Feb 2025 | EXERCISE | Axsome Therapeutics, Inc. | 12,000 | 3.50 USD | deriv |
| 14 Feb 2025 | EXERCISE | Axsome Therapeutics, Inc. | 3,000 | 3.50 USD | deriv |
| 27 Feb 2024 | GRANT_AWARD | Axsome Therapeutics, Inc. | 15,774 | 0.00 USD | deriv |
| 27 Feb 2024 | GRANT_AWARD | Axsome Therapeutics, Inc. | 28,722 | 0.00 USD | deriv |
| 02 Mar 2023 | GRANT_AWARD | Axsome Therapeutics, Inc. | 20,554 | 0.00 USD | deriv |
| 02 Mar 2023 | GRANT_AWARD | Axsome Therapeutics, Inc. | 36,246 | 0.00 USD | deriv |
| 04 Mar 2022 | GRANT_AWARD | Axsome Therapeutics, Inc. | 77,872 | 0.00 USD | deriv |
| 04 Mar 2022 | GRANT_AWARD | Axsome Therapeutics, Inc. | 41,176 | 0.00 USD | deriv |
| 18 Nov 2021 | PURCHASE | Axsome Therapeutics, Inc. | 527 | 35.50 USD | |
| 18 Nov 2021 | PURCHASE | Axsome Therapeutics, Inc. | 142 | 35.20 USD | |
| 18 Nov 2021 | PURCHASE | Axsome Therapeutics, Inc. | 145 | 34.30 USD | first after silence |
| 18 Nov 2021 | PURCHASE | Axsome Therapeutics, Inc. | 141 | 35.43 USD | |
| 12 Nov 2021 | GRANT_AWARD | Axsome Therapeutics, Inc. | 36,086 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 18 Nov 2021.